KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $674.1 million.

  • Emergent BioSolutions' Non-Current Assets fell 1743.02% to $674.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year decrease of 2685.84%. This contributed to the annual value of $791.0 million for FY2024, which is 3083.85% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Non-Current Assets is $674.1 million, which was down 1743.02% from $697.6 million recorded in Q2 2025.
  • Emergent BioSolutions' Non-Current Assets' 5-year high stood at $2.0 billion during Q4 2022, with a 5-year trough of $674.1 million in Q3 2025.
  • Over the past 5 years, Emergent BioSolutions' median Non-Current Assets value was $1.4 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 1588.46% in 2022, then tumbled by 4152.56% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Non-Current Assets (Quarter) stood at $1.7 billion in 2021, then rose by 15.88% to $2.0 billion in 2022, then crashed by 41.53% to $1.1 billion in 2023, then tumbled by 30.84% to $791.0 million in 2024, then decreased by 14.78% to $674.1 million in 2025.
  • Its Non-Current Assets was $674.1 million in Q3 2025, compared to $697.6 million in Q2 2025 and $719.3 million in Q1 2025.